Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




JIB 2010 Focuses on Human Health and Environment

By LabMedica International staff writers
Posted on 14 Oct 2010
The 55th Journées Internationales de Biologie (JIB) will take place on November 2-5, 2010, at the Centre des Nouvelles Industries et Technologies (CNIT; Paris, France). More...
The scientific sessions will focus on improving understanding of the impact of the environment on human health.

The aim of the sessions is to help biologists understand the physiological and pathological phenomena caused by changes in the environment. Chaired by Jean François Bach, permanent secretary of the Academy of Sciences, the scientific program will involve talks on subjects such as biologic response and adaptation mechanisms to the environment; autoimmunity and allergies; the environment and cardiovascular pathologies; the environment and reprotoxins; and nutrition, health and the environment.

The congress will present an opportunity for discussions on the French reform of the medical biology profession. Jean Benoit, President of the SDB [Union of Biologists], commented, "The scale of the task is immense but it gives biologists of all kinds the opportunity to redefine the contours of a profession at the forefront of technological innovation and one that anticipates the major evolutions in medicine.”

For the last three years, the JIB congress has highlighted molecular biology by devoting a space to it at the heart of the show. The molecular biology initiatives pavilion (BioMI) pavilion is dedicated to technologic advances in the process of detecting and curing pathological conditions. This year the JIB will welcome three new companies to the center: Bio Evolution (Italy), Coris Bioconcept (Gembloux, Belgium), and Laboratoires Nephrotek Sas (France).

A scientific session is being organized for BioMI that will be moderated by Prof. Michel Vidaud, head of the biochemistry and molecular genetics department of Beaujon hospital (Paris; France). The program will cover technologic innovations and discussions in areas such as applications of genomic techniques to diagnostics.

More than 1900 congress participants are expected and 96 presentations scheduled. There will be close to 200 exhibitors, including leaders from the in vitro diagnostics (IVD) sector, and an anticipated 10,000 visitors. One hundred and fifty-four new products have been announced and 114 of these will be launched at the show.

Related Links:
Journées Internationales de Biologie
Bio Evolution
Coris Bioconcept
Laboratoires Nephrotek Sas
Beaujon hospital


New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.